Visanne (VI-san, dienogest), a new oral progestin for pelvic pain caused by endometriosis

December 2011

Women in Canada will be using Visanne (VI-san, dienogest), a new oral progestin for pelvic pain caused by endometriosis.

Endometriosis affects up to 10% of reproductive-age women. It causes pain due to growth of endometrial tissue outside the uterus.

Hormonal treatments help reduce pain by inhibiting the growth of endometrial tissue and suppressing menstruation.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Geriatrics too many anticholinergics in an elderly patient
Insomnia Sublinox (zolpidem) will compete with zopiclone (Imovane, etc) as a new NON-benzodiazepine hypnotic for insomnia
Vitamins & Minerals vitamin E INCREASES the risk of prostate cancer
Infectious Diseases Which antibiotics should you recommend for urinary tract infections in elderly patients
Women's Health Visanne (VI-san, dienogest), a new oral progestin for pelvic pain caused by endometriosis
Dermatology new topical acne treatment called Aczone (dapsone) gel
Psychiatry The use of atypical antipsychotics is growing
Gout Dosing and drug interactions with colchicine for acute gout are still causing confusion
Diabetes Byetta WITH Lantus for type 2 diabetes
Potassium All the different oral potassium products bring up questions about which one to use
NSAIDs Patients with uncomplicated hypertension often ask if they can take NSAIDs (ibuprofen, celecoxib, etc) due to label warnings